Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRIS: IV Iron for Post-Op Recovery
NCT05744219Phase 3Recruiting
- Start
- Sep 2024
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative anemia comparing Iv Iron with Placebo (2 arms). Primary endpoint: Composite of death, RBC transfusions, severe anemia, and QoL at 5 weeks. Started Sep 2024; status: recruiting.
02
Drugs
ferric carboxymaltose
03
Conditions
postoperative anemia
Beyond the preview
Go deeper on NCT05744219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05744219.